Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2021-02-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$146.7m reported value +20.2% vs Q3 2020
31positions
88.5%in top 10
1 new 3 added 0 reduced 0 sold out vs Q3 2020

Holdings, Q4 2020

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 857,494 $73.5m50.11% 50.11% UnchangedShares held: Q1 2020 857.5k, Q2 2020 857.5k, Q3 2020 857.5k, Q4 2020 857.5k
2 APPLIED THERAPEUTICS INC COM APLT APLT 851,551 $18.8m12.78% 12.78% AddedShares held: Q1 2020 642.1k, Q2 2020 650.2k, Q3 2020 735.0k, Q4 2020 851.6k +116.6k +116,571 15.9%
3 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 694,232 $8.5m5.82% 5.82% AddedShares held: Q1 2020 475.2k, Q2 2020 525.2k, Q3 2020 595.2k, Q4 2020 694.2k +99.0k +98,994 16.6%
4 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 5,045,870 $6.3m4.30% 4.30% UnchangedShares held: Q1 2020 5.0m, Q2 2020 5.0m, Q3 2020 5.0m, Q4 2020 5.0m
5 Orgenesis, Inc. COM COM 1,316,364 $5.9m4.04% 4.04% UnchangedShares held: Q1 2020 0, Q2 2020 1.3m, Q3 2020 1.3m, Q4 2020 1.3m
6 ABEONA THERAPEUTICS INC COM COM 2,859,767 $4.5m3.06% 3.06% UnchangedShares held: Q1 2020 2.9m, Q2 2020 2.9m, Q3 2020 2.9m, Q4 2020 2.9m
7 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 569,405 $3.9m2.66% 2.66% UnchangedShares held: Q1 2020 569.4k, Q2 2020 569.4k, Q3 2020 569.4k, Q4 2020 569.4k
8 ANAVEX LIFE SCIENCES CORP COM NEW AVXL AVXL 670,789 $3.6m2.47% 2.47% AddedShares held: Q1 2020 724.2k, Q2 2020 724.2k, Q3 2020 620.8k, Q4 2020 670.8k +50.0k +50,000 8.1%
9 BLACKSTONE GROUP L P COM UNIT LTD BX BX 40,000 $2.6m1.77% 1.77% UnchangedShares held: Q1 2020 80.0k, Q2 2020 40.0k, Q3 2020 40.0k, Q4 2020 40.0k
10 EXICURE INC COM XCUR XCUR 1,277,777 $2.3m1.54% 1.54% UnchangedShares held: Q1 2020 1.3m, Q2 2020 1.3m, Q3 2020 1.3m, Q4 2020 1.3m
11 CENTURYLINK INC COM CTL CTL 220,000 $2.1m1.46% 1.46% UnchangedShares held: Q1 2020 220.0k, Q2 2020 220.0k, Q3 2020 220.0k, Q4 2020 220.0k
12 ENTERA BIO LTD SHS ENTX ENTX 1,741,363 $1.9m1.28% 1.28% UnchangedShares held: Q1 2020 1.7m, Q2 2020 1.7m, Q3 2020 1.7m, Q4 2020 1.7m
13 DOW INC COM DOW DOW 30,000 $1.7m1.14% 1.14% UnchangedShares held: Q1 2020 30.0k, Q2 2020 30.0k, Q3 2020 30.0k, Q4 2020 30.0k
14 CORTEVA INC COM CTVA CTVA 30,000 $1.2m0.79% 0.79% UnchangedShares held: Q1 2020 30.0k, Q2 2020 30.0k, Q3 2020 30.0k, Q4 2020 30.0k
15 MOLECULAR TEMPLATES INC COM COM 113,905 $1.1m0.73% 0.73% UnchangedShares held: Q1 2020 113.9k, Q2 2020 113.9k, Q3 2020 113.9k, Q4 2020 113.9k
16 DUPONT DE NEMOURS INC COM DWDP DWDP 15,000 $1.1m0.73% 0.73% UnchangedShares held: Q1 2020 15.0k, Q2 2020 15.0k, Q3 2020 15.0k, Q4 2020 15.0k
17 SOLIGENIX INC COM COM 787,830 $1.0m0.69% 0.69% UnchangedShares held: Q1 2020 787.8k, Q2 2020 787.8k, Q3 2020 787.8k, Q4 2020 787.8k
18 BIOXCEL THERAPEUTICS INC COM COM 20,000 $924.0k0.63% 0.63% UnchangedShares held: Q1 2020 20.0k, Q2 2020 20.0k, Q3 2020 20.0k, Q4 2020 20.0k
19 SEABRIDGE GOLD INC COM COM 32,000 $674.0k0.46% 0.46% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 32.0k, Q4 2020 32.0k
20 MAVERIX METALS INC COM NEW COM NEW 115,000 $628.0k0.43% 0.43% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 115.0k, Q4 2020 115.0k
21 ALTIMMUNE INC COM NEW ALT ALT 50,000 $564.0k0.38% 0.38% NewShares held: Q1 2020 0, Q2 2020 0, Q3 2020 0, Q4 2020 50.0k
22 OSISKO GOLD ROYALTIES LTD COM COM 190,000 $551.0k0.38% 0.38% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 190.0k, Q4 2020 190.0k
23 AGNICO EAGLE MINES LTD COM AEM AEM 6,900 $487.0k0.33% 0.33% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 6.9k, Q4 2020 6.9k
24 EQUINOX GOLD CORP COM EQX EQX 45,500 $470.0k0.32% 0.32% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 45.5k, Q4 2020 45.5k
25 FRANCO NEV CORP COM FNV FNV 3,750 $470.0k0.32% 0.32% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 3.8k, Q4 2020 3.8k
26 KIRKLAND LAKE GOLD LTD COM KL KL 10,750 $444.0k0.30% 0.30% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 10.8k, Q4 2020 10.8k
27 FORTUNA SILVER MINES INC COM COM 43,700 $360.0k0.25% 0.25% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 43.7k, Q4 2020 43.7k
28 MAG SILVER CORP COM MAG MAG 17,300 $355.0k0.24% 0.24% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 17.3k, Q4 2020 17.3k
29 SILVERCREST METALS INC COM SIL SIL 31,000 $347.0k0.24% 0.24% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 31.0k, Q4 2020 31.0k
30 PAN AMERN SILVER CORP COM PAAS PAAS 8,200 $283.0k0.19% 0.19% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 8.2k, Q4 2020 8.2k
31 SILVERCORP METALS INC COM SVM SVM 36,500 $244.0k0.17% 0.17% UnchangedShares held: Q1 2020 0, Q2 2020 0, Q3 2020 36.5k, Q4 2020 36.5k

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08